Trial Profile
Randomized Phase II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) Versus 5-FU, l-LV and Oxaliplatin Combination Therapy (mFOLFOX6) in Patients With Untreated Metastatic Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2012
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Mar 2012 Planned end date changed from 1 Jul 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 21 Jan 2012 Overall survival results presented at the 2012 Gastrointestinal Cancers Symposium.